04:28 AM EST, 11/06/2025 (MT Newswires) -- Caris Life Sciences ( CAI ) reported Q3 net income Wednesday of $0.08 per diluted share, swinging from a loss of $2.59 a year earlier.

Analysts polled by FactSet expected a loss of $0.18.

Revenue for the quarter ended Sept. 30 was $216.8 million, up from $101.6 million a year earlier.

Analysts surveyed by FactSet expected $174.1 million.

For 2025, the company increased its revenue outlook to between $720 million and $730 million, up from its previous guidance of $675 million to $685 million.

Analysts polled by FactSet expect $710.9 million.

Shares of the company were up over 7% in recent after-hours activity.